Difference between revisions of "Palmar plantar erythrodysesthesia risk factors"

Jump to: navigation, search
 
Line 8: Line 8:
  
 
==Risk Factors==
 
==Risk Factors==
Exposure to chemotherapeutic agents has been proven to be an established risk factor. Occurrence of this condition has been linked to dose and prolonged chemotherapeutic drug exposure. The data is limited to support any other associated risk factors as the pathophysiology of palmar plantar erythrodysesthesia.
+
* Exposure to chemotherapeutic agents has been proven to be an established risk factor.  
 +
* Occurrence of this condition has been linked to dose and prolonged chemotherapeutic drug exposure.  
 +
* The data is limited to support any other associated risk factors as the pathophysiology of palmar plantar erythrodysesthesia.
 
==References==
 
==References==
 
{{reflist|2}}
 
{{reflist|2}}

Latest revision as of 15:57, 12 July 2019

Palmar plantar erythrodysesthesia Microchapters

Home

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Palmar plantar erythrodysesthesia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Palmar plantar erythrodysesthesia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Palmar plantar erythrodysesthesia risk factors

CDC on Palmar plantar erythrodysesthesia risk factors

Palmar plantar erythrodysesthesia risk factors in the news

Blogs on Palmar plantar erythrodysesthesia risk factors

Directions to Hospitals Treating Palmar plantar erythrodysesthesia

Risk calculators and risk factors for Palmar plantar erythrodysesthesia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]

Overview

The most common and established risk factors are chemotherapeutic agents. The severity of the condition depends on the dose and frequency of the agent.

Risk Factors

  • Exposure to chemotherapeutic agents has been proven to be an established risk factor.
  • Occurrence of this condition has been linked to dose and prolonged chemotherapeutic drug exposure.
  • The data is limited to support any other associated risk factors as the pathophysiology of palmar plantar erythrodysesthesia.

References


Linked-in.jpg